Coca-Cola Europacific Partners Earnings: Nice Profitability Expansion in a Challenging Year

We think Coca-Cola Europacific Partners stock is moderately overvalued.

Red Coca-Cola logo bottle cap on October 8, 2020 in Krakow, Poland
Getty Images

Key Morningstar Metrics for Coca-Cola Europacific Partners

What We Thought of Coca-Cola Europacific Partners’ Earnings

CCEP’s 2025 results included comparable year-over-year revenue growth of 2.3% and volume growth of 2.7%. Operating profit increased 5.4%, with bottom-line improvement in both segments. Shares were flat at the market open on Feb. 17.

Why it matters: Revenue came in below our expectations, with third-quarter headwinds from Germany and Indonesia carrying into the fourth quarter. However, full-year profitability growth exceeded our forecasts, driven by effective pricing and efficiency initiatives.

  • Full-year 2026 targets are broadly similar to 2025 guidance, with revenue growth of 3%-4% and operating profit growth of 7%. We think the firm can meet its targets, with an added revenue boost from 2026 FIFA World Cup activations.
  • CCEP’s ready-to-drink alcohol category performed strongly despite industry weakness in the spirits sector, with revenue up 10%. We expect continued growth in the ready-to-drink alcohol category; however, we are cognizant of intensifying competition.

The bottom line: We are raising our fair value estimate for narrow-moat CCEP to GBX 6,300 from GBX 5,400. At current levels, shares are around 15% overvalued. Our fair value estimate increase stems from lower operating expense forecasts; however, we remain cautious about the potential for gross margin expansion given The Coca-Cola Company’s control over bottling contracts.

  • Our revenue growth projections are broadly unchanged and in line with management’s medium-term target of 4%.
  • We continue to view CCEP’s emerging-market expansion favorably for driving long-term growth and see other bottlers following suit; Coca-Cola HBC is acquiring Coca-Cola Beverages Africa.

Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.